$MFST Commented CEO Bruce J. Schoengood, "We are very pleased with the positive results of the Skin Surface Temperature Study and we are excited to complete the one remaining lab test currently being performed by Intertek Labs. We are working very diligently with Intertek and have successfully completed many of the tests as required as part of the EC 60601-1-2 Medical Electrical Equipment Part 1-2: General Requirements for Safety: Electromagnetic Compatibility test as requested by the FDA. Once all the test results are completed, we will submit all the data to Medifirst's FDA consultants to prepare and submit the company response." Continued Schoengood, "Although the deadline to respond back to the FDA is June, we are still on schedule to complete our response well in advance of the deadline, and we will continue to update our progress and completion of our response to be submitted back to the FDA."